Last 12 months
Inside the activity.
2 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 1 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 10 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2026 Filed Oct 7, 2026 20:00 UTC |
MILNE GEORGE M JRDirector
|
SaleCommon Stock | 30,000 | $27.70 | $830,904.00 |
DisclosureSEC source: 0001193125-26-416950 · ownership.xml · nonDerivative · entry 1 MILNE GEORGE M JR · CIK 0001179552 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 782,881 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on April 28, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.36 to $28.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:00 UTC |
FRATES JAMES MChief Financial Officer
|
SaleCommon Stock | 1,042 | $33.23 | $34,625.87 |
DisclosureSEC source: 0001193125-26-390509 · ownership.xml · nonDerivative · entry 2 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,625 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units. Such sales were automatic and not at the discretion of the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.84 to $33.45. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:00 UTC |
FRATES JAMES MChief Financial Officer
|
SaleCommon Stock | 9,768 | $32.27 | $315,194.80 |
DisclosureSEC source: 0001193125-26-390509 · ownership.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,667 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.805 to $32.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:00 UTC |
Bedrosian Camille LChief Medical Officer
|
SaleCommon Stock | 2,081 | $33.09 | $68,864.24 |
DisclosureSEC source: 0001193125-26-390510 · ownership.xml · nonDerivative · entry 2 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,064 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units. Such sales were automatic and not at the discretion of the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.85 to $33.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:00 UTC |
Bedrosian Camille LChief Medical Officer
|
SaleCommon Stock | 7,947 | $32.21 | $256,003.86 |
DisclosureSEC source: 0001193125-26-390510 · ownership.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,145 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.76 to $32.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:00 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 919 | $33.15 | $30,463.75 |
DisclosureSEC source: 0001193125-26-390507 · ownership.xml · nonDerivative · entry 2 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,613,123 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units. Such sales were automatic and not at the discretion of the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.855 to $33.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:00 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 29,545 | $32.16 | $950,040.16 |
DisclosureSEC source: 0001193125-26-390507 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,614,042 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.81 to $32.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:00 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 1,439 | $33.16 | $47,710.33 |
DisclosureSEC source: 0001193125-26-390506 · ownership.xml · nonDerivative · entry 2 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,613,056 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units. Such sales were automatic and not at the discretion of the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.87 to $33.39. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:00 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 29,025 | $32.13 | $932,552.93 |
DisclosureSEC source: 0001193125-26-390506 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,614,495 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.81 to $32.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:00 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 11 | $33.34 | $366.74 |
DisclosureSEC source: 0001193125-26-390508 · ownership.xml · nonDerivative · entry 2 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,838 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:00 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 9,525 | $32.46 | $309,139.59 |
DisclosureSEC source: 0001193125-26-390508 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,849 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.34 to $33.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:00 UTC |
Firestone KarenDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.05 | $0.00 |
DisclosureSEC source: 0001193125-26-380152 · ownership.xml · derivative · entry 4 Firestone Karen · CIK 0001969821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2035-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:00 UTC |
Firestone KarenDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001193125-26-380152 · ownership.xml · derivative · entry 3 Firestone Karen · CIK 0001969821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2034-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:00 UTC |
Firestone KarenDirector
|
Exercise / conversionCommon Stock | 25,000 | $5.05 | $126,250.00 |
DisclosureSEC source: 0001193125-26-380152 · ownership.xml · nonDerivative · entry 2 Firestone Karen · CIK 0001969821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:00 UTC |
Firestone KarenDirector
|
Exercise / conversionCommon Stock | 25,000 | $1.76 | $44,000.00 |
DisclosureSEC source: 0001193125-26-380152 · ownership.xml · nonDerivative · entry 1 Firestone Karen · CIK 0001969821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2026 Filed Aug 21, 2026 01:00 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
GrantCommon Stock | 60,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-359675 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,643,587 F1 · shares: The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics. Shares subject to the PSU vested on August 18, 2026. Read SEC document |
| August 18, 2026 Filed Aug 21, 2026 01:00 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
GrantCommon Stock | 60,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-359678 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,643,520 F1 · shares: The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics. Shares subject to the PSU vested on August 18, 2026. Read SEC document |
| August 18, 2026 Filed Aug 21, 2026 01:00 UTC |
FRATES JAMES MChief Financial Officer
|
GrantCommon Stock | 22,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-359679 · ownership.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,435 F1 · shares: The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics. Shares subject to the PSU vested on August 18, 2026. Read SEC document |
| August 18, 2026 Filed Aug 21, 2026 01:00 UTC |
Mazzariello GinaChief Legal Officer
|
GrantCommon Stock | 21,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-359677 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,374 F1 · shares: The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics. Shares subject to the PSU vested on August 18, 2026. Read SEC document |
| August 18, 2026 Filed Aug 21, 2026 01:00 UTC |
Bedrosian Camille LChief Medical Officer
|
GrantCommon Stock | 22,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-359676 · ownership.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,092 F1 · shares: The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics. Shares subject to the PSU vested on August 18, 2026. Read SEC document |
| July 10, 2026 Filed Jul 13, 2026 20:00 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 15,000 | $17.61 | $264,121.50 |
DisclosureSEC source: 0001193125-26-301996 · ownership.xml · nonDerivative · entry 2 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 179,090 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on April 9, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.15 to $18.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:00 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 15,000 | $18.32 | $274,746.00 |
DisclosureSEC source: 0001193125-26-301996 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 194,090 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on April 9, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.92 to $18.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 20:00 UTC |
MILNE GEORGE M JRDirector
|
GrantStock Option (right to buy) · Derivative | 24,372 | $0.00 Strike: $14.31 | $0.00 |
DisclosureSEC source: 0001193125-26-261638 · ownership.xml · derivative · entry 1 MILNE GEORGE M JR · CIK 0001179552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,372 Underlying: Common Stock · 24,372 shares Expires 2036-06-03 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 16:00 UTC |
Zeiher Bernhardt GDirector
|
GrantStock Option (right to buy) · Derivative | 24,372 | $0.00 Strike: $14.31 | $0.00 |
DisclosureSEC source: 0001193125-26-261647 · ownership.xml · derivative · entry 1 Zeiher Bernhardt G · CIK 0001971421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,372 Underlying: Common Stock · 24,372 shares Expires 2036-06-03 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 20:00 UTC |
FONTEYNE PAUL R.Director
|
GrantStock Option (right to buy) · Derivative | 24,372 | $0.00 Strike: $14.31 | $0.00 |
DisclosureSEC source: 0001193125-26-261637 · ownership.xml · derivative · entry 1 FONTEYNE PAUL R. · CIK 0001727550 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,372 Underlying: Common Stock · 24,372 shares Expires 2036-06-03 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 20:00 UTC |
Quimi DaphneDirector
|
GrantStock Option (right to buy) · Derivative | 24,372 | $0.00 Strike: $14.31 | $0.00 |
DisclosureSEC source: 0001193125-26-261640 · ownership.xml · derivative · entry 1 Quimi Daphne · CIK 0001543031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,372 Underlying: Common Stock · 24,372 shares Expires 2036-06-03 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 20:00 UTC |
Firestone KarenDirector
|
GrantStock Option (right to buy) · Derivative | 24,372 | $0.00 Strike: $14.31 | $0.00 |
DisclosureSEC source: 0001193125-26-261641 · ownership.xml · derivative · entry 1 Firestone Karen · CIK 0001969821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,372 Underlying: Common Stock · 24,372 shares Expires 2036-06-03 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:00 UTC |
Firestone KarenDirector
|
PurchaseCommon Stock | 3,800 | $13.51 | $51,338.00 |
DisclosureSEC source: 0001193125-26-239216 · ownership.xml · nonDerivative · entry 1 Firestone Karen · CIK 0001969821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,900 Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:00 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 373,295 | $0.00 Strike: $14.10 | $0.00 |
DisclosureSEC source: 0001193125-26-098440 · ownership.xml · derivative · entry 2 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,295 Underlying: Common Stock · 373,295 shares Expires 2036-03-05 F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:00 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
GrantCommon Stock | 248,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-098440 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,583,548 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:00 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 373,295 | $0.00 Strike: $14.10 | $0.00 |
DisclosureSEC source: 0001193125-26-098437 · ownership.xml · derivative · entry 2 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,295 Underlying: Common Stock · 373,295 shares Expires 2036-03-05 F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:00 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
GrantCommon Stock | 248,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-098437 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,583,481 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:00 UTC |
Mazzariello GinaChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 111,990 | $0.00 Strike: $14.10 | $0.00 |
DisclosureSEC source: 0001193125-26-098439 · ownership.xml · derivative · entry 2 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,990 Underlying: Common Stock · 111,990 shares Expires 2036-03-05 F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:00 UTC |
Mazzariello GinaChief Legal Officer
|
GrantCommon Stock | 74,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-098439 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,090 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:00 UTC |
FRATES JAMES MChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 143,985 | $0.00 Strike: $14.10 | $0.00 |
DisclosureSEC source: 0001193125-26-098438 · ownership.xml · derivative · entry 5 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,985 Underlying: Common Stock · 143,985 shares Expires 2036-03-05 F5 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:00 UTC |
FRATES JAMES MChief Financial Officer
|
GrantCommon Stock | 95,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-098438 · ownership.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,628 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:00 UTC |
Bedrosian Camille LChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 143,985 | $0.00 Strike: $14.10 | $0.00 |
DisclosureSEC source: 0001193125-26-098436 · ownership.xml · derivative · entry 2 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,985 Underlying: Common Stock · 143,985 shares Expires 2036-03-05 F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:00 UTC |
Bedrosian Camille LChief Medical Officer
|
GrantCommon Stock | 95,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-098436 · ownership.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,285 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:00 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 29,282 | $14.48 | $424,120.49 |
DisclosureSEC source: 0001193125-26-091442 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,334,683 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.450 to $15.160. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:00 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 29,282 | $14.47 | $423,760.32 |
DisclosureSEC source: 0001193125-26-091443 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,334,616 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.450 to $15.360. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:00 UTC |
Bedrosian Camille LChief Medical Officer
|
SaleCommon Stock | 6,461 | $14.58 | $94,205.26 |
DisclosureSEC source: 0001193125-26-091440 · ownership.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,295 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.440 to $14.945. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:00 UTC |
FRATES JAMES MChief Financial Officer
|
SaleCommon Stock | 7,909 | $14.52 | $114,851.33 |
DisclosureSEC source: 0001193125-26-091438 · ownership.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,638 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.450 to $15.385. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:00 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 6,844 | $14.52 | $99,378.30 |
DisclosureSEC source: 0001193125-26-091436 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,430 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.400 to $15.070. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:00 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 3,419 | $14.14 | $48,352.18 |
DisclosureSEC source: 0001193125-26-071460 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,274 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.030 to $14.220. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:05 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 15,500 | $14.68 | $227,592.70 |
DisclosureSEC source: 0001193125-26-037552 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,363,965 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.510 to $14.760. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:05 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 15,500 | $14.69 | $227,617.50 |
DisclosureSEC source: 0001193125-26-037544 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,363,898 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.510 to $14.760. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:05 UTC |
FRATES JAMES MChief Financial Officer
|
SaleCommon Stock | 3,557 | $14.65 | $52,096.89 |
DisclosureSEC source: 0001193125-26-037553 · ownership.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,547 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.460 to $14.790. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:05 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 3,448 | $14.65 | $50,515.61 |
DisclosureSEC source: 0001193125-26-037548 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,693 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.470 to $14.810. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 02:46 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,847 | $0.00 Strike: $7.57 | $0.00 |
DisclosureSEC source: 0001193125-26-017056 · ownership.xml · derivative · entry 6 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,847 shares Expires 2026-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable. The option is due to expire on February 19, 2026. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 02:46 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 1,995 | $13.89 | $27,701.17 |
DisclosureSEC source: 0001193125-26-017056 · ownership.xml · nonDerivative · entry 4 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,379,398 F1 · kind: Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.83 to $13.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.